Health TrialsbyHealthPanel

Efficacy Of Inpatient Pulmonary Rehabilitation Program In Elderly Patients With Acute Exacerbation Of COPD

ConditionsCOPD Received PRElderly (People Aged 65 or More)COPDCOPD Acute Exacerbation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-78
SponsorAl-Azhar University

About this trial

The study aimed to identify the effect of early pulmonary rehabilitation in elderly patients with Acute exacerbation (AE) of COPD (AECOPD) in exercise tolerance, dyspnea, sleep quality, fatigue, and time to discharge from hospital.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with acute exacerbation of COPD in both gender

Patient older than 65 years

Patient with clear consciousness

Patients had been diagnosed with shortness of breath or dyspnea that was not caused by heart disease, pneumothorax, or pulmonary edema

Disqualifiers

Patient with systolic blood pressure lower than 90 mmHg

Patient with an unstable psychological status, hemoptysis, pneumothorax, pulmonary edema

Trial design

Design model

Parallel

Treatments tested in this trial

  • physical therapy program

    Other intervention

    Group A will performed a physical therapy program that completed two daily sessions till discharge from the hospital .Exercise training starts from randomisation until hospital discharge,and administered twice per day, seven times per week. The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Group A will perform physical therapy programExperimental treatment 1 intervention
Group B: Group B will the control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Exercise tolerance

The 6 minute walk test(6MWT)in meter to asses exercise tolerance

Time frame
The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

Secondary outcomes

1

Dyspnea

(The Modified Medical Research Council (mMRC )scale to assess Dyspnea)

Time frame
The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks
2

Length of hospital stay(LOS)

(Number of days to assess length of stay in hospital (LOS) from admission to hospital to discharge from hospital)

Time frame
The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks
3

Fatigue level

Fatigue Severity Scale (FSS)to assess fatigue)

Time frame
The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Al-Azhar University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: